| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Dabigatran | 5 | 2018 | 204 | 1.60 | Why? |
| Bacterial Adhesion | 4 | 2019 | 69 | 1.31 | Why? |
| Staphylococcus aureus | 6 | 2019 | 844 | 0.95 | Why? |
| Rivaroxaban | 8 | 2019 | 467 | 0.85 | Why? |
| Itraconazole | 1 | 2021 | 135 | 0.80 | Why? |
| Coagulase | 5 | 2019 | 44 | 0.79 | Why? |
| Extracellular Matrix Proteins | 4 | 2018 | 95 | 0.70 | Why? |
| Calcium-Binding Proteins | 4 | 2018 | 121 | 0.69 | Why? |
| Venous Thromboembolism | 14 | 2021 | 4273 | 0.69 | Why? |
| Factor Xa Inhibitors | 7 | 2018 | 490 | 0.68 | Why? |
| Endocarditis, Bacterial | 2 | 2019 | 344 | 0.67 | Why? |
| Blood Coagulation Tests | 2 | 2018 | 855 | 0.60 | Why? |
| Anticoagulants | 18 | 2019 | 9563 | 0.58 | Why? |
| Staphylococcal Infections | 3 | 2019 | 1099 | 0.58 | Why? |
| Platelet Factor 4 | 1 | 2018 | 385 | 0.55 | Why? |
| Aortic Valve | 1 | 2019 | 664 | 0.50 | Why? |
| Thiazoles | 4 | 2018 | 496 | 0.50 | Why? |
| Heart Valve Prosthesis | 2 | 2017 | 533 | 0.46 | Why? |
| Pyridines | 4 | 2018 | 680 | 0.46 | Why? |
| Aspirin | 6 | 2019 | 1043 | 0.44 | Why? |
| Blood Platelets | 3 | 2019 | 1704 | 0.43 | Why? |
| Hemorrhage | 11 | 2019 | 3013 | 0.42 | Why? |
| Vitamin K | 3 | 2018 | 263 | 0.42 | Why? |
| Atrial Fibrillation | 4 | 2018 | 2320 | 0.41 | Why? |
| Fibrinolysin | 1 | 2010 | 80 | 0.40 | Why? |
| Amino Acids, Branched-Chain | 2 | 2018 | 8 | 0.39 | Why? |
| Blood Pressure Monitoring, Ambulatory | 3 | 2018 | 341 | 0.38 | Why? |
| Platelet Membrane Glycoproteins | 2 | 2019 | 42 | 0.38 | Why? |
| Heart Transplantation | 2 | 2018 | 1293 | 0.38 | Why? |
| Echocardiography, Doppler | 4 | 2018 | 269 | 0.37 | Why? |
| Ventricular Function, Left | 4 | 2018 | 1555 | 0.36 | Why? |
| Dalteparin | 2 | 2018 | 57 | 0.36 | Why? |
| Antibodies, Monoclonal, Humanized | 3 | 2018 | 9335 | 0.35 | Why? |
| Thrombolytic Therapy | 3 | 2019 | 2218 | 0.33 | Why? |
| Platelet Aggregation Inhibitors | 6 | 2019 | 1671 | 0.32 | Why? |
| Mothers | 1 | 2017 | 1624 | 0.32 | Why? |
| Antithrombins | 3 | 2018 | 353 | 0.31 | Why? |
| Thrombophilia | 1 | 2018 | 1935 | 0.29 | Why? |
| von Willebrand Factor | 4 | 2019 | 668 | 0.29 | Why? |
| Belgium | 10 | 2021 | 2064 | 0.29 | Why? |
| Ventricular Dysfunction, Left | 3 | 2018 | 993 | 0.29 | Why? |
| Coronary Thrombosis | 1 | 2010 | 433 | 0.29 | Why? |
| Retinal Vessels | 2 | 2018 | 255 | 0.28 | Why? |
| Venous Thrombosis | 6 | 2021 | 2739 | 0.27 | Why? |
| Infusions, Intravenous | 4 | 2018 | 1224 | 0.27 | Why? |
| ADAMTS13 Protein | 2 | 2018 | 363 | 0.27 | Why? |
| Peripheral Arterial Disease | 3 | 2019 | 471 | 0.27 | Why? |
| Stress, Mechanical | 3 | 2018 | 143 | 0.27 | Why? |
| Fibrin | 3 | 2019 | 145 | 0.26 | Why? |
| Glomerular Filtration Rate | 3 | 2018 | 1262 | 0.26 | Why? |
| Inflammation | 3 | 2020 | 13255 | 0.24 | Why? |
| Heart Failure | 3 | 2018 | 6638 | 0.24 | Why? |
| Receptors, Cell Surface | 2 | 2017 | 586 | 0.24 | Why? |
| Proof of Concept Study | 2 | 2021 | 696 | 0.23 | Why? |
| Hypertension | 6 | 2019 | 8895 | 0.23 | Why? |
| Intermittent Pneumatic Compression Devices | 2 | 2018 | 40 | 0.22 | Why? |
| Atherosclerosis | 2 | 2019 | 768 | 0.22 | Why? |
| Fibronectins | 2 | 2018 | 92 | 0.21 | Why? |
| Vascular Grafting | 1 | 2019 | 23 | 0.20 | Why? |
| RNA, Transfer, Amino Acid-Specific | 1 | 2018 | 1 | 0.20 | Why? |
| Human Umbilical Vein Endothelial Cells | 2 | 2018 | 286 | 0.19 | Why? |
| Peptide Fragments | 1 | 2010 | 2075 | 0.19 | Why? |
| Retinal Artery | 1 | 2018 | 16 | 0.19 | Why? |
| Vascular Patency | 1 | 2019 | 96 | 0.19 | Why? |
| Urokinase-Type Plasminogen Activator | 1 | 2019 | 62 | 0.19 | Why? |
| Fibrin Fibrinogen Degradation Products | 3 | 2021 | 5993 | 0.19 | Why? |
| Nephrolithiasis | 1 | 2018 | 11 | 0.18 | Why? |
| Lemierre Syndrome | 1 | 2018 | 28 | 0.18 | Why? |
| Drug Substitution | 2 | 2018 | 385 | 0.18 | Why? |
| Vitamin K Deficiency | 1 | 2018 | 30 | 0.18 | Why? |
| Cadherins | 1 | 2018 | 145 | 0.18 | Why? |
| Vascular Remodeling | 1 | 2018 | 99 | 0.18 | Why? |
| Heart Ventricles | 2 | 2017 | 1139 | 0.18 | Why? |
| Graft Occlusion, Vascular | 1 | 2019 | 105 | 0.18 | Why? |
| Blood Pressure | 3 | 2018 | 2198 | 0.18 | Why? |
| Denervation | 1 | 2017 | 26 | 0.17 | Why? |
| Preoperative Period | 1 | 2018 | 271 | 0.17 | Why? |
| Pipecolic Acids | 1 | 2018 | 84 | 0.17 | Why? |
| Mesentery | 1 | 2017 | 43 | 0.17 | Why? |
| Dose-Response Relationship, Drug | 3 | 2018 | 3776 | 0.17 | Why? |
| Albuminuria | 1 | 2018 | 164 | 0.17 | Why? |
| Adsorption | 1 | 2018 | 261 | 0.17 | Why? |
| Heart Valves | 1 | 2017 | 52 | 0.17 | Why? |
| Perioperative Care | 2 | 2018 | 1329 | 0.16 | Why? |
| Heparin, Low-Molecular-Weight | 4 | 2020 | 1731 | 0.16 | Why? |
| Standard of Care | 2 | 2021 | 1297 | 0.16 | Why? |
| Automation | 1 | 2019 | 429 | 0.16 | Why? |
| Enhancer Elements, Genetic | 1 | 2016 | 48 | 0.16 | Why? |
| Fibrinolytic Agents | 2 | 2019 | 1702 | 0.16 | Why? |
| Lead | 1 | 2017 | 94 | 0.16 | Why? |
| Cadmium | 1 | 2017 | 105 | 0.15 | Why? |
| Endothelium | 1 | 2019 | 460 | 0.15 | Why? |
| Lower Extremity | 2 | 2018 | 593 | 0.15 | Why? |
| Portal Vein | 1 | 2018 | 193 | 0.15 | Why? |
| Carotid Artery Diseases | 1 | 2019 | 251 | 0.15 | Why? |
| Azithromycin | 2 | 2021 | 3943 | 0.15 | Why? |
| Blood Pressure Determination | 1 | 2019 | 450 | 0.15 | Why? |
| Uterine Hemorrhage | 1 | 2015 | 73 | 0.15 | Why? |
| Photography | 1 | 2018 | 255 | 0.15 | Why? |
| Calcinosis | 1 | 2018 | 240 | 0.15 | Why? |
| Mesocricetus | 1 | 2021 | 1847 | 0.15 | Why? |
| Lymphoma | 1 | 2020 | 522 | 0.15 | Why? |
| Biomarkers | 8 | 2018 | 23361 | 0.15 | Why? |
| Mendelian Randomization Analysis | 1 | 2018 | 317 | 0.15 | Why? |
| Female | 44 | 2021 | 380317 | 0.15 | Why? |
| Disease Models, Animal | 3 | 2021 | 10998 | 0.15 | Why? |
| Male | 45 | 2021 | 367725 | 0.15 | Why? |
| Thrombin | 1 | 2018 | 325 | 0.14 | Why? |
| Cell Adhesion Molecules | 1 | 2018 | 472 | 0.14 | Why? |
| Polypharmacy | 1 | 2017 | 347 | 0.14 | Why? |
| Receptors, IgG | 1 | 2018 | 578 | 0.14 | Why? |
| Angiography | 2 | 2018 | 301 | 0.14 | Why? |
| Administration, Oral | 5 | 2018 | 2340 | 0.13 | Why? |
| Drug Interactions | 2 | 2018 | 1653 | 0.13 | Why? |
| Treatment Outcome | 13 | 2022 | 51732 | 0.13 | Why? |
| Microvessels | 1 | 2018 | 490 | 0.13 | Why? |
| Diastole | 3 | 2018 | 168 | 0.13 | Why? |
| Blood Vessels | 1 | 2015 | 228 | 0.13 | Why? |
| Warfarin | 1 | 2017 | 402 | 0.13 | Why? |
| Purpura, Thrombotic Thrombocytopenic | 1 | 2018 | 284 | 0.13 | Why? |
| Mitral Valve | 1 | 2017 | 342 | 0.13 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2019 | 669 | 0.13 | Why? |
| Antigens, CD | 1 | 2018 | 984 | 0.12 | Why? |
| Insulin Resistance | 1 | 2018 | 669 | 0.12 | Why? |
| Bacteriological Techniques | 1 | 2015 | 239 | 0.12 | Why? |
| Neoplasms | 5 | 2019 | 17251 | 0.12 | Why? |
| Mitral Valve Insufficiency | 1 | 2017 | 302 | 0.12 | Why? |
| Blood Coagulation | 4 | 2018 | 2768 | 0.12 | Why? |
| Thrombosis | 4 | 2019 | 7504 | 0.12 | Why? |
| Infant, Premature | 1 | 2018 | 883 | 0.12 | Why? |
| Middle Aged | 32 | 2021 | 270681 | 0.12 | Why? |
| Humans | 62 | 2022 | 930598 | 0.12 | Why? |
| Surgical Procedures, Operative | 2 | 2018 | 2662 | 0.11 | Why? |
| Circadian Rhythm | 1 | 2018 | 607 | 0.11 | Why? |
| Registries | 4 | 2019 | 12327 | 0.11 | Why? |
| Hemostasis | 1 | 2018 | 811 | 0.11 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2018 | 665 | 0.11 | Why? |
| DNA Methylation | 1 | 2016 | 688 | 0.11 | Why? |
| Immunization, Passive | 3 | 2022 | 10067 | 0.11 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.11 | Why? |
| Enoxaparin | 1 | 2018 | 1064 | 0.11 | Why? |
| Tissue Plasminogen Activator | 1 | 2017 | 778 | 0.10 | Why? |
| Heart Valve Prosthesis Implantation | 1 | 2017 | 552 | 0.10 | Why? |
| Fibrinolysis | 2 | 2018 | 521 | 0.10 | Why? |
| Aged | 27 | 2021 | 215776 | 0.10 | Why? |
| Alleles | 1 | 2016 | 1557 | 0.10 | Why? |
| Decision Support Techniques | 1 | 2017 | 903 | 0.10 | Why? |
| Drug Monitoring | 1 | 2017 | 1408 | 0.10 | Why? |
| Cardiac Catheterization | 1 | 2017 | 882 | 0.10 | Why? |
| Software | 2 | 2019 | 2501 | 0.10 | Why? |
| Injections, Intravenous | 1 | 2010 | 381 | 0.10 | Why? |
| Adult | 27 | 2022 | 244371 | 0.10 | Why? |
| Postoperative Complications | 2 | 2018 | 5861 | 0.09 | Why? |
| Endothelium, Vascular | 2 | 2018 | 1751 | 0.09 | Why? |
| Drug Evaluation, Preclinical | 1 | 2021 | 3347 | 0.09 | Why? |
| Follow-Up Studies | 8 | 2021 | 17020 | 0.09 | Why? |
| Cognition | 1 | 2018 | 1394 | 0.09 | Why? |
| Plasma | 1 | 2018 | 1809 | 0.09 | Why? |
| Animals | 7 | 2021 | 78931 | 0.09 | Why? |
| Patient Discharge | 2 | 2021 | 5696 | 0.09 | Why? |
| Bacteremia | 1 | 2018 | 1372 | 0.08 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.08 | Why? |
| Electrocardiography | 2 | 2018 | 3957 | 0.08 | Why? |
| Oligopeptides | 1 | 2010 | 576 | 0.08 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.08 | Why? |
| Double-Blind Method | 4 | 2018 | 5988 | 0.08 | Why? |
| Adaptive Immunity | 1 | 2018 | 2585 | 0.08 | Why? |
| Environmental Exposure | 1 | 2017 | 1558 | 0.08 | Why? |
| Early Detection of Cancer | 1 | 2018 | 1956 | 0.08 | Why? |
| Myocardium | 1 | 2018 | 2323 | 0.08 | Why? |
| Predictive Value of Tests | 5 | 2018 | 9537 | 0.08 | Why? |
| Aged, 80 and over | 14 | 2021 | 88759 | 0.07 | Why? |
| Intention to Treat Analysis | 2 | 2017 | 673 | 0.07 | Why? |
| Risk Factors | 13 | 2019 | 71621 | 0.07 | Why? |
| Cardiovascular Diseases | 3 | 2019 | 11497 | 0.07 | Why? |
| Environmental Monitoring | 1 | 2017 | 3143 | 0.07 | Why? |
| Particulate Matter | 1 | 2017 | 3249 | 0.07 | Why? |
| Mice | 3 | 2019 | 21357 | 0.07 | Why? |
| Phosphorylation | 2 | 2018 | 1060 | 0.07 | Why? |
| Length of Stay | 2 | 2021 | 11042 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.07 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.07 | Why? |
| Risk Assessment | 5 | 2019 | 25439 | 0.07 | Why? |
| Recurrence | 3 | 2018 | 3675 | 0.07 | Why? |
| Prospective Studies | 8 | 2022 | 43301 | 0.07 | Why? |
| Incidence | 7 | 2020 | 25622 | 0.07 | Why? |
| Pulmonary Embolism | 2 | 2021 | 4775 | 0.06 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.06 | Why? |
| Dogs | 1 | 2010 | 2529 | 0.06 | Why? |
| Time Factors | 7 | 2019 | 31397 | 0.06 | Why? |
| Prognosis | 7 | 2018 | 32490 | 0.06 | Why? |
| Cells, Cultured | 3 | 2018 | 5835 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.06 | Why? |
| Young Adult | 11 | 2021 | 93724 | 0.06 | Why? |
| Anti-Bacterial Agents | 2 | 2021 | 10083 | 0.06 | Why? |
| Reproducibility of Results | 4 | 2019 | 11304 | 0.06 | Why? |
| Drug Therapy, Combination | 3 | 2020 | 7268 | 0.06 | Why? |
| Antihypertensive Agents | 1 | 2013 | 1962 | 0.06 | Why? |
| Protein Binding | 4 | 2018 | 11430 | 0.05 | Why? |
| Aprotinin | 1 | 2020 | 63 | 0.05 | Why? |
| Stroke | 3 | 2019 | 8839 | 0.05 | Why? |
| Drug Administration Schedule | 2 | 2018 | 2324 | 0.05 | Why? |
| Evidence-Based Medicine | 1 | 2013 | 3228 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Critical Care | 3 | 2020 | 14081 | 0.05 | Why? |
| Protein Interaction Domains and Motifs | 2 | 2018 | 2134 | 0.05 | Why? |
| Combined Modality Therapy | 2 | 2020 | 3395 | 0.05 | Why? |
| Kallikreins | 1 | 2020 | 158 | 0.05 | Why? |
| Transfer RNA Aminoacylation | 1 | 2018 | 1 | 0.05 | Why? |
| Lactococcus lactis | 1 | 2018 | 45 | 0.05 | Why? |
| Microfilament Proteins | 1 | 2018 | 45 | 0.05 | Why? |
| Adhesins, Bacterial | 1 | 2018 | 39 | 0.05 | Why? |
| Limb Salvage | 1 | 2019 | 124 | 0.05 | Why? |
| src-Family Kinases | 1 | 2018 | 48 | 0.05 | Why? |
| Fusobacterium necrophorum | 1 | 2018 | 20 | 0.05 | Why? |
| Case-Control Studies | 4 | 2018 | 17671 | 0.05 | Why? |
| Stockings, Compression | 1 | 2018 | 20 | 0.05 | Why? |
| Masked Hypertension | 1 | 2018 | 15 | 0.05 | Why? |
| Neoplasms, Unknown Primary | 1 | 2018 | 28 | 0.05 | Why? |
| White Coat Hypertension | 1 | 2018 | 24 | 0.05 | Why? |
| Bradykinin | 1 | 2020 | 203 | 0.05 | Why? |
| Air Pollution | 1 | 2017 | 3504 | 0.05 | Why? |
| Antibodies, Viral | 2 | 2022 | 51949 | 0.05 | Why? |
| Embryo, Mammalian | 1 | 2018 | 86 | 0.05 | Why? |
| Metalloendopeptidases | 1 | 2018 | 35 | 0.05 | Why? |
| Bacterial Proteins | 2 | 2018 | 1318 | 0.05 | Why? |
| Term Birth | 1 | 2018 | 56 | 0.04 | Why? |
| Thrombin Time | 1 | 2017 | 46 | 0.04 | Why? |
| Aminoacyltransferases | 1 | 2017 | 10 | 0.04 | Why? |
| Plasminogen | 1 | 2018 | 58 | 0.04 | Why? |
| Kaplan-Meier Estimate | 2 | 2017 | 4260 | 0.04 | Why? |
| Dipeptides | 1 | 2018 | 106 | 0.04 | Why? |
| Splanchnic Circulation | 1 | 2017 | 37 | 0.04 | Why? |
| Brachial Artery | 1 | 2018 | 107 | 0.04 | Why? |
| Societies, Medical | 3 | 2018 | 6907 | 0.04 | Why? |
| Multivariate Analysis | 2 | 2019 | 5440 | 0.04 | Why? |
| Carotid Arteries | 1 | 2019 | 182 | 0.04 | Why? |
| Anesthesiology | 2 | 2018 | 1163 | 0.04 | Why? |
| Ventricular Fibrillation | 1 | 2018 | 126 | 0.04 | Why? |
| Chromatin Immunoprecipitation | 1 | 2016 | 53 | 0.04 | Why? |
| Antibodies, Neutralizing | 2 | 2022 | 25288 | 0.04 | Why? |
| Vena Cava Filters | 1 | 2018 | 89 | 0.04 | Why? |
| Echocardiography, Doppler, Color | 1 | 2017 | 114 | 0.04 | Why? |
| Global Burden of Disease | 1 | 2020 | 531 | 0.04 | Why? |
| Introns | 1 | 2016 | 112 | 0.04 | Why? |
| Protein Folding | 1 | 2018 | 270 | 0.04 | Why? |
| Myocardial Revascularization | 1 | 2019 | 267 | 0.04 | Why? |
| Hemostatics | 1 | 2018 | 142 | 0.04 | Why? |
| Blood Coagulation Factors | 1 | 2018 | 223 | 0.04 | Why? |
| Risk | 2 | 2019 | 5288 | 0.04 | Why? |
| Comorbidity | 2 | 2018 | 34796 | 0.04 | Why? |
| Regional Blood Flow | 1 | 2017 | 172 | 0.04 | Why? |
| Partial Thromboplastin Time | 1 | 2018 | 436 | 0.04 | Why? |
| Amputation | 1 | 2019 | 331 | 0.04 | Why? |
| Child | 4 | 2019 | 70012 | 0.04 | Why? |
| Antigens, CD34 | 1 | 2016 | 125 | 0.04 | Why? |
| Systole | 1 | 2017 | 252 | 0.04 | Why? |
| Blood Flow Velocity | 1 | 2017 | 193 | 0.04 | Why? |
| Injections, Subcutaneous | 1 | 2018 | 647 | 0.04 | Why? |
| Unnecessary Procedures | 1 | 2017 | 175 | 0.04 | Why? |
| Echocardiography, Three-Dimensional | 1 | 2017 | 135 | 0.04 | Why? |
| Pilot Projects | 2 | 2018 | 5182 | 0.04 | Why? |
| Capillaries | 1 | 2018 | 257 | 0.04 | Why? |
| Catheterization, Peripheral | 1 | 2019 | 249 | 0.04 | Why? |
| Observer Variation | 1 | 2018 | 622 | 0.04 | Why? |
| Arginine | 1 | 2018 | 377 | 0.04 | Why? |
| CpG Islands | 1 | 2016 | 230 | 0.04 | Why? |
| Cardiomyopathy, Dilated | 1 | 2018 | 251 | 0.04 | Why? |
| Aorta | 1 | 2018 | 355 | 0.04 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.03 | Why? |
| Microscopy, Fluorescence | 1 | 2015 | 335 | 0.03 | Why? |
| Office Visits | 1 | 2019 | 489 | 0.03 | Why? |
| Microcirculation | 1 | 2018 | 447 | 0.03 | Why? |
| Megakaryocytes | 1 | 2016 | 274 | 0.03 | Why? |
| Clinical Decision-Making | 2 | 2018 | 3755 | 0.03 | Why? |
| Critical Illness | 1 | 2018 | 17281 | 0.03 | Why? |
| Administration, Intravenous | 1 | 2018 | 1115 | 0.03 | Why? |
| Models, Genetic | 1 | 2016 | 434 | 0.03 | Why? |
| European Union | 1 | 2018 | 565 | 0.03 | Why? |
| Platelet Activation | 1 | 2018 | 660 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2021 | 2437 | 0.03 | Why? |
| Histones | 1 | 2016 | 371 | 0.03 | Why? |
| Haplotypes | 1 | 2017 | 853 | 0.03 | Why? |
| Hematopoietic Stem Cells | 1 | 2016 | 321 | 0.03 | Why? |
| Cell Membrane | 1 | 2018 | 743 | 0.03 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2017 | 3607 | 0.03 | Why? |
| Diagnosis, Differential | 2 | 2018 | 7220 | 0.03 | Why? |
| Echocardiography, Transesophageal | 1 | 2017 | 447 | 0.03 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2018 | 881 | 0.03 | Why? |
| Protein Processing, Post-Translational | 1 | 2016 | 634 | 0.03 | Why? |
| Epitope Mapping | 1 | 2018 | 1240 | 0.03 | Why? |
| Safety | 1 | 2020 | 1583 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2018 | 1654 | 0.03 | Why? |
| Databases, Factual | 2 | 2018 | 6248 | 0.03 | Why? |
| Metabolomics | 1 | 2018 | 921 | 0.03 | Why? |
| Pyridones | 1 | 2018 | 738 | 0.03 | Why? |
| Fibrinogen | 1 | 2018 | 1048 | 0.03 | Why? |
| Age Factors | 3 | 2018 | 21039 | 0.03 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.03 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 1165 | 0.03 | Why? |
| Environmental Pollutants | 1 | 2017 | 320 | 0.03 | Why? |
| Secondary Prevention | 1 | 2017 | 762 | 0.03 | Why? |
| In Vitro Techniques | 1 | 2015 | 1027 | 0.03 | Why? |
| Muscle, Skeletal | 1 | 2018 | 915 | 0.03 | Why? |
| Ultrasonography | 2 | 2018 | 4409 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2018 | 2219 | 0.03 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.03 | Why? |
| Myocardial Ischemia | 1 | 2018 | 781 | 0.03 | Why? |
| Drug Hypersensitivity | 1 | 2017 | 401 | 0.03 | Why? |
| Random Allocation | 1 | 2013 | 773 | 0.03 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2021 | 10649 | 0.03 | Why? |
| Pulmonary Artery | 1 | 2018 | 803 | 0.03 | Why? |
| Antibodies | 1 | 2017 | 846 | 0.03 | Why? |
| Transcription, Genetic | 1 | 2016 | 1326 | 0.03 | Why? |
| Cell Differentiation | 1 | 2016 | 1338 | 0.03 | Why? |
| Switzerland | 1 | 2018 | 2738 | 0.03 | Why? |
| Israel | 1 | 2019 | 2751 | 0.02 | Why? |
| Epigenesis, Genetic | 1 | 2016 | 711 | 0.02 | Why? |
| Hemodynamics | 1 | 2018 | 1562 | 0.02 | Why? |
| Sulfonamides | 1 | 2018 | 1294 | 0.02 | Why? |
| Netherlands | 1 | 2018 | 3533 | 0.02 | Why? |
| Medication Adherence | 1 | 2018 | 1270 | 0.02 | Why? |
| Cell Proliferation | 1 | 2016 | 1973 | 0.02 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.02 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.02 | Why? |
| Immune System | 1 | 2018 | 1479 | 0.02 | Why? |
| Heart | 1 | 2018 | 1791 | 0.02 | Why? |
| Cysteine Endopeptidases | 1 | 2017 | 1557 | 0.02 | Why? |
| Endothelial Cells | 1 | 2018 | 2048 | 0.02 | Why? |
| Pyrazoles | 1 | 2018 | 1791 | 0.02 | Why? |
| Protein Conformation | 1 | 2018 | 4386 | 0.02 | Why? |
| Stroke Volume | 1 | 2017 | 2153 | 0.02 | Why? |
| Autoantibodies | 1 | 2018 | 2094 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Premature Birth | 1 | 2018 | 2151 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.02 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Outpatients | 1 | 2019 | 3417 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2018 | 3444 | 0.02 | Why? |
| Antirheumatic Agents | 1 | 2020 | 3023 | 0.02 | Why? |
| Retrospective Studies | 4 | 2019 | 105322 | 0.02 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.02 | Why? |
| Epitopes | 1 | 2018 | 4113 | 0.02 | Why? |
| International Cooperation | 1 | 2019 | 3436 | 0.02 | Why? |
| Protein Domains | 1 | 2018 | 6563 | 0.02 | Why? |
| Coronary Artery Disease | 1 | 2019 | 2570 | 0.02 | Why? |
| Thrombocytopenia | 1 | 2018 | 2093 | 0.02 | Why? |
| Acute Coronary Syndrome | 1 | 2018 | 2107 | 0.02 | Why? |
| Patient Selection | 1 | 2018 | 4560 | 0.02 | Why? |
| Cardiology | 1 | 2019 | 2873 | 0.02 | Why? |
| Myocardial Infarction | 1 | 2019 | 3361 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| HEK293 Cells | 1 | 2016 | 8394 | 0.01 | Why? |
| France | 1 | 2019 | 12074 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.01 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 7868 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.01 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.01 | Why? |
| Percutaneous Coronary Intervention | 1 | 2018 | 3646 | 0.01 | Why? |
| Proportional Hazards Models | 1 | 2013 | 6543 | 0.01 | Why? |
| Europe | 1 | 2018 | 12702 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.01 | Why? |
| Brain | 1 | 2018 | 5133 | 0.01 | Why? |
| Ambulatory Care | 1 | 2017 | 4947 | 0.01 | Why? |
| Spain | 1 | 2019 | 15545 | 0.01 | Why? |
| Hospitalization | 2 | 2022 | 54280 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Italy | 1 | 2019 | 38444 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2021 | 243684 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.01 | Why? |
| Intensive Care Units | 1 | 2018 | 29594 | 0.01 | Why? |
| United States | 1 | 2017 | 46150 | 0.01 | Why? |